Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (231-240 of 267) with videos related to

Pageof 27
Sort By:
Diabetes Care|April 12, 2023
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low ThresholdLaurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
The Journal of Pathology. Clinical Research|September 19, 2024
Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trialsHanna Pulaski, Shraddha S Mehta, Laryssa C Manigat, et al.
Virchows Archiv : an International Journal of Pathology|July 2, 2020
Fifty years of impact on liver pathology: a history of the GnomesMichael Torbenson, Valeer Desmet, Helmut Denk, et al.
Gastroenterology|November 20, 2015
Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in HumansRaed Daher, Caroline Kannengiesser, Dounia Houamel, et al.
Gut|September 5, 2015
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expressionXavier Loyer, Valérie Paradis, Carole Hénique, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2022
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLDSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR CohortMarion Delplanque, Xavier Amiot, Dominique Wendum, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paperMatti Aapro, Alain Astier, Riccardo Audisio, et al.
Pageof 27

Showing results (231-240 of 267) with videos related to

Sort By:
Pageof 27
Diabetes Care|April 12, 2023
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low ThresholdLaurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
The Journal of Pathology. Clinical Research|September 19, 2024
Validation of a whole slide image management system for metabolic-associated steatohepatitis for clinical trialsHanna Pulaski, Shraddha S Mehta, Laryssa C Manigat, et al.
Virchows Archiv : an International Journal of Pathology|July 2, 2020
Fifty years of impact on liver pathology: a history of the GnomesMichael Torbenson, Valeer Desmet, Helmut Denk, et al.
Gastroenterology|November 20, 2015
Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in HumansRaed Daher, Caroline Kannengiesser, Dounia Houamel, et al.
Gut|September 5, 2015
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expressionXavier Loyer, Valérie Paradis, Carole Hénique, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2022
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLDSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2025
Liver Disease Complicating Familial Mediterranean Fever: A Study on 66 Patients Out of 533 Adult From the JIR CohortMarion Delplanque, Xavier Amiot, Dominique Wendum, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paperMatti Aapro, Alain Astier, Riccardo Audisio, et al.
Pageof 27